GEN Exclusives

More »

GEN News Highlights

More »
Nov 30, 2012

CSL to Use PharmaJet Needle-Free Injector for Flu Vaccine

  • CSL Limited has inked an agreement with PharmaJet to enable its Afluria® influenza vaccine to be delivered with the PharmaJet Stratis® needle-free jet injector. The company plans to seek FDA approval for the 2013–2014 flu season.

    Adding PharmaJet jet injectors to the Afluria label will expand the delivery options for flu vaccine administration, and increase immunization compliance, according to the companies.

    PharmaJet injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating needle-stick injuries, needle anxiety, and sharps disposal management. The PharmaJet Stratis device received FDA 510(k) marketing clearance in June.

    In January 2011, the Centers for Disease Control gave PharmaJet a grant to develop needle-free injection devices for intradermal vaccine delivery. The benefits of intradermal delivery reportedly include reduction of the amount of vaccine required by as much as 80% in some cases, leading to cost savings and expanded coverage for vaccines in limited supply.

    Afluria is a nonadjuvanted seasonal influenza vaccine sold in two different formulations: thimerosal-free, pre-filled syringes, and in multi-dose vials.

    PharmaJet’s collaboration with CSL involves conducting a Phase IV clinical study to demonstrate the immunogenicity and safety of Afluria when administered with PharmaJet Stratis needle-free device.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »